Matthew Galsky is a medical oncologist with a clinical and research focus on genitourinary malignancies and, since 2010, director of genitourinary medical oncology at The Tisch Cancer Institute of the Icahn School of Medicine at Mount Sinai. His research and speaking has focused on the clinical development of novel therapies for genitourinary cancers with a particular focus on bladder cancer. Journals that have published his work include the Journal of Clinical Oncology, Journal of the National Cancer Institute, Lancet Oncology, and The Lancet. Galsky, who previously worked at Memorial Sloan-Kettering Cancer Center, is a recipient of the Richard E. Rosenfield Faculty Achievement Award and the Danielson Translational Innovation Award. (Festival Underwriter Presenter)